Literature DB >> 30997192

Hyperprogressive disease: a distinct effect of immunotherapy?

Vinita Popat1, David E Gerber2,3,4.   

Abstract

Entities:  

Year:  2019        PMID： 30997192      PMCID： PMC6424758          DOI： 10.21037/jtd.2019.01.97

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  The dark side of immunotherapy: challenges facing the new hope in cancer treatment.

Authors:  Eduard Teixidor; Joaquim Bosch-Barrera
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Immunotherapy Use in Patients With Lung Cancer and Comorbidities.

Authors:  Mitchell S von Itzstein; Amrit S Gonugunta; Helen G Mayo; John D Minna; David E Gerber
Journal:  Cancer J       Date:  2020 Nov/Dec       Impact factor: 2.074

Review 3.  The Potential of T Cell Factor 1 in Sustaining CD8+ T Lymphocyte-Directed Anti-Tumor Immunity.

Authors:  Sungmin Jung; Jea-Hyun Baek
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

4.  PD-1 Blockade Aggravates Epstein-Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations.

Authors:  Valery Volk; Sebastian J Theobald; Simon Danisch; Sahamoddin Khailaie; Maja Kalbarczyk; Andreas Schneider; Julia Bialek-Waldmann; Nicole Krönke; Yun Deng; Britta Eiz-Vesper; Anna Christina Dragon; Constantin von Kaisenberg; Stefan Lienenklaus; Andre Bleich; James Keck; Michael Meyer-Hermann; Frank Klawonn; Wolfgang Hammerschmidt; Henri-Jacques Delecluse; Christian Münz; Friedrich Feuerhake; Renata Stripecke
Journal:  Front Oncol       Date:  2021-01-12       Impact factor: 6.244

5.  Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report.

Authors:  Amrit S Gonugunta; Mitchell S von Itzstein; David E Gerber
Journal:  J Med Case Rep       Date:  2022-07-25

Review 6.  The dark side of immunotherapy.

Authors:  Nwanneka Okwundu; Douglas Grossman; Siwen Hu-Lieskovan; Kenneth F Grossmann; Umang Swami
Journal:  Ann Transl Med       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.